GSK Travel Health - Home  
Products Services/Support Travel Healthy   External links     Order
    Home
         
 
Travel scene
  Products
 
For more information click on the product logo. Print-friendly version
   
≥>
Product Schedules Booster Length of
protection
Age range, yrs
ACWY Vax product information
Meningococcal polysaccharide groups A, C, Y and W135 vaccine 1 Dose

High-risk
adults and children over 5 yrs old:
every 5 yrs3

Children aged 2–5:
every 2–3 yrs3

At least 3 yrs

2 yrs +
Ambirix
Paediatric

Hepatitis A (inactivated) and Hepatitis B (rDNA) vaccine (adsorbed)
0, 6–12 months Hepatitis A not established but at least 10 yrs

Hepatitis B: not established

Need for booster should be drawn from monovalent vaccine experience

The Green Book: Hepatitis B vaccine booster ~5 yrs after primary immunisation
Hepatitis A: at least 10 yrs

Hepatitis B: not established

Maintain protective anti-HBs antibody titre of
≥10 IU/l in immunocompromised
1–15 yrs

EngerixB product information

Adult

Hepatitis B vaccine

0, 1, 6 months

0, 1, 2 & 12 months

0, 7, 21 days & 12 months (18 yrs+) (for exceptional circumstances)

0, 6 months (11–15 yrs) (where low risk during course)

Refer to Summary of Product Characteristics2

The Green Book: ~5 yrs after primary immunisation, once only, for those at continuing risk1
Maintain protective anti-HBs antibody titre of
≥10 IU/l in immunocompromised
16 yrs + (11–15 yrs on 2 dose schedule)
Paediatric

Hepatitis B vaccine
0, 1, 6 months

0, 1, 2 & 12 months
(more rapid response)
Refer to Summary of Product Characteristics2

The Green Book: ~5 yrs after primary immunisation, once only, for those at continuing risk1
Maintain protective anti-HBs antibody titre of
≥10 IU/l in immunocompromised
0–15 yrs
Havrix product information
Hepatitis A (antigen) vaccine 1 Dose Booster
6–12 months for continuous
protection

Can boost up to 5 yrs after
1st dose
1st dose –
at least 1 yr

Booster provides at least 25 yrs of protection in most people based upon predictive modelling
16 yrs +
Havrix product information
Hepatitis A (antigen) vaccine 1 Dose Booster
6–12 months for continuous
protection

Can boost up to 3 yrs after
1st dose
1st dose –
at least 1 yr

Booster provides
at least
10 yrs of protection
1–15 yrs
Hepatyrix product information
Hepatitis A (inactivated) and Typhoid polysaccharide vaccine (adsorbed) 1 Dose Hepatitis A
booster
6–12 months for continuous
protection

Not applicable for typhoid
Booster provides at least 10 yrs Hepatitis A protection

Typhoid
revaccination
every 3 yrs
if at continued risk
15 yrs +
Rotarix product information
Rotavirus vaccine
For more information click on the product logo
Twinrix product information
Adult

Hepatitis A (inactivated) and Hepatitis B (rDNA) vaccine (adsorbed)
0, 1, 6 months

0, 7, 21 days,
12 months
(18 yrs +)
(for exceptional circumstances)
Hepatitis A: not established but antibodies persist for at least 10 yrs

Hepatitis B: not established

Need for booster should be drawn from monovalent vaccine experience

The Green Book: Hepatitis B Vaccine booster ~5 yrs after primary immunisation, once only, for those at continuing risk1
Hepatitis A: at least 10 yrs

Hepatitis B: not established

Maintain protective anti-HBs antibody titre of
≥10 IU/l in immunocompromised
16 yrs +
Twinrix product information
Paediatric

Hepatitis A (inactivated) and Hepatitis B vaccine(rDNA) vaccine (adsorbed)
0, 1, 6 months Hepatitis A: not established but antibodies persist for at least 10 yrs

Hepatitis B: not established

Need for booster should be drawn from monovalent vaccine experience

The Green Book: Hepatitis B Vaccine booster ~5 yrs after primary immunisation, once only, for those at continuing risk1
Hepatitis A: at least 10 yrs

Hepatitis B: not established

Maintain protective anti-HBs antibody titre of
≥10 IU/l in immunocompromised
1–15 yrs
Typherix product information
Typhoid polysaccharide vaccine 1 Dose   Up to 3 yrs

Revaccinate every 3 yrs if at continued risk
2 yrs +
Varilrix product information
Varicella/chickenpox vaccine
For more information click on the product logo

 

Product Schedules
Malarone product information
250 mg atovaquone
100 mg proguanil

For prophylaxis: Take 1-2 days before arrival, 1 daily while in malarial areas for a maximum of 28 days, 1 daily for 7 days on return. Malarone is not recommended for malaria prophylaxis in persons under 40 kg bodyweight

Malarone product information
62.5 mg atovaquone
25 mg proguanil

For prophylaxis: Take 1-2 days before arrival, daily while in malarial areas for a maximum of 28 days, daily for 7 days on return. Contact GSK Travel Health for a dose calculator. Safety and effectiveness of Malarone Paediatric for prophylaxis of malaria in children who weigh less than 11 kg has not been established

top

      Page updated: November 2009    VCG/WEB/09/39682/1
The content on this site has been compiled by GlaxoSmithKline for healthcare professionals. Content for members of the public is located here.
GSK

© 2001 - 2009 GlaxoSmithKline UK Limited. All rights reserved.
Registered in England and Wales No. 4310159.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to GlaxoSmithKline on 0808 100 9997

Legal Statement | Your privacy | Contact us
GSK Travel Health